CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis

Europe • Euronext Oslo • OSL:CONTX • SE0014731154

3.7 NOK
-0.06 (-1.6%)
Last: Feb 5, 2026, 03:57 PM
Fundamental Rating

5

Taking everything into account, CONTX scores 5 out of 10 in our fundamental rating. CONTX was compared to 12 industry peers in the Health Care Technology industry. CONTX has an excellent profitability rating, but there are some minor concerns on its financial health. CONTX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year CONTX was profitable.
  • CONTX had a positive operating cash flow in the past year.
  • Of the past 5 years CONTX 4 years were profitable.
  • CONTX had a positive operating cash flow in each of the past 5 years.
CONTX.OL Yearly Net Income VS EBIT VS OCF VS FCFCONTX.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

1.2 Ratios

  • CONTX has a Return On Assets of 3.07%. This is comparable to the rest of the industry: CONTX outperforms 58.33% of its industry peers.
  • Looking at the Return On Equity, with a value of 3.95%, CONTX is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 2.67%, CONTX is in line with its industry, outperforming 41.67% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CONTX is significantly above the industry average of 8.64%.
  • The 3 year average ROIC (36.72%) for CONTX is well above the current ROIC(2.67%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 3.07%
ROE 3.95%
ROIC 2.67%
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
CONTX.OL Yearly ROA, ROE, ROICCONTX.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

1.3 Margins

  • CONTX has a Profit Margin (3.17%) which is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of CONTX has grown nicely.
  • CONTX's Operating Margin of 2.90% is in line compared to the rest of the industry. CONTX outperforms 41.67% of its industry peers.
  • In the last couple of years the Operating Margin of CONTX has grown nicely.
  • CONTX has a better Gross Margin (97.62%) than 91.67% of its industry peers.
  • In the last couple of years the Gross Margin of CONTX has remained more or less at the same level.
Industry RankSector Rank
OM 2.9%
PM (TTM) 3.17%
GM 97.62%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
CONTX.OL Yearly Profit, Operating, Gross MarginsCONTX.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80 100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CONTX is creating value.
  • CONTX has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CONTX remains at a similar level compared to 5 years ago.
  • Compared to 1 year ago, CONTX has a worse debt to assets ratio.
CONTX.OL Yearly Shares OutstandingCONTX.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CONTX.OL Yearly Total Debt VS Total AssetsCONTX.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • The Debt to FCF ratio of CONTX is 5.01, which is a neutral value as it means it would take CONTX, 5.01 years of fcf income to pay off all of its debts.
  • CONTX has a Debt to FCF ratio (5.01) which is comparable to the rest of the industry.
  • CONTX has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
  • CONTX's Debt to Equity ratio of 0.07 is fine compared to the rest of the industry. CONTX outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 5.01
Altman-Z N/A
ROIC/WACC0.38
WACC7.07%
CONTX.OL Yearly LT Debt VS Equity VS FCFCONTX.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

  • CONTX has a Current Ratio of 4.79. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 4.79, CONTX belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
  • CONTX has a Quick Ratio of 4.70. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
  • CONTX's Quick ratio of 4.70 is amongst the best of the industry. CONTX outperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 4.79
Quick Ratio 4.7
CONTX.OL Yearly Current Assets VS Current LiabilitesCONTX.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • CONTX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -83.70%.
  • Measured over the past years, CONTX shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.26% on average per year.
  • Looking at the last year, CONTX shows a very negative growth in Revenue. The Revenue has decreased by -13.08% in the last year.
  • CONTX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.51% yearly.
EPS 1Y (TTM)-83.7%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%-100%
Revenue 1Y (TTM)-13.08%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%-21.24%

3.2 Future

  • Based on estimates for the next years, CONTX will show a decrease in Earnings Per Share. The EPS will decrease by -7.44% on average per year.
  • Based on estimates for the next years, CONTX will show a small growth in Revenue. The Revenue will grow by 0.49% on average per year.
EPS Next Y-103.45%
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%
EPS Next 5YN/A
Revenue Next Year-17.19%
Revenue Next 2Y-6.46%
Revenue Next 3Y-3.79%
Revenue Next 5Y0.49%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CONTX.OL Yearly Revenue VS EstimatesCONTX.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M
CONTX.OL Yearly EPS VS EstimatesCONTX.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 0.2 0.3 0.4 0.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 74.00, CONTX can be considered very expensive at the moment.
  • CONTX's Price/Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Earnings ratio is at 27.67. CONTX is valued rather expensively when compared to this.
  • CONTX is valuated quite expensively with a Price/Forward Earnings ratio of 30.29.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CONTX is on the same level as its industry peers.
  • The average S&P500 Price/Forward Earnings ratio is at 27.20. CONTX is around the same levels.
Industry RankSector Rank
PE 74
Fwd PE 30.29
CONTX.OL Price Earnings VS Forward Price EarningsCONTX.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • CONTX's Enterprise Value to EBITDA is on the same level as the industry average.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as CONTX.
Industry RankSector Rank
P/FCF 158.69
EV/EBITDA 18.57
CONTX.OL Per share dataCONTX.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • CONTX has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as CONTX's earnings are expected to decrease with -7.44% in the coming years.
PEG (NY)N/A
PEG (5Y)2.71
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 4.18%, CONTX is a good candidate for dividend investing.
  • CONTX's Dividend Yield is rather good when compared to the industry average which is at 2.20. CONTX pays more dividend than 83.33% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, CONTX pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.18%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DP0%
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%
CONTX.OL Yearly Income VS Free CF VS DividendCONTX.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

More info and screens

Find the best dividend stocksShow peers with best dividend

CONTEXTVISION AB

OSL:CONTX (2/5/2026, 3:57:42 PM)

3.7

-0.06 (-1.6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-06
Earnings (Next)02-19
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap286.27M
Revenue(TTM)112.76M
Net Income(TTM)3.58M
Analysts40
Price Target4.08 (10.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.18%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-100%
Min EPS beat(2)-100%
Max EPS beat(2)-100%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.52%
Min Revenue beat(2)-22.13%
Max Revenue beat(2)-4.91%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-20%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)50%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.52%
Valuation
Industry RankSector Rank
PE 74
Fwd PE 30.29
P/S 2.35
P/FCF 158.69
P/OCF 29.89
P/B 2.93
P/tB 3.02
EV/EBITDA 18.57
EPS(TTM)0.05
EY1.35%
EPS(NY)0.12
Fwd EY3.3%
FCF(TTM)0.02
FCFY0.63%
OCF(TTM)0.12
OCFY3.35%
SpS1.57
BVpS1.26
TBVpS1.23
PEG (NY)N/A
PEG (5Y)2.71
Graham Number1.19
Profitability
Industry RankSector Rank
ROA 3.07%
ROE 3.95%
ROCE 3.38%
ROIC 2.67%
ROICexc 8.83%
ROICexgc 9.67%
OM 2.9%
PM (TTM) 3.17%
GM 97.62%
FCFM 1.48%
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.4%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexgc growth 3Y-39.35%
ROICexgc growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score5
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 5.01
Debt/EBITDA 0.55
Cap/Depr 92.01%
Cap/Sales 6.39%
Interest Coverage 250
Cash Conversion 79.95%
Profit Quality 46.76%
Current Ratio 4.79
Quick Ratio 4.7
Altman-Z N/A
F-Score5
WACC7.07%
ROIC/WACC0.38
Cap/Depr(3y)55.3%
Cap/Depr(5y)58.55%
Cap/Sales(3y)3.81%
Cap/Sales(5y)5.04%
Profit Quality(3y)103.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-83.7%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%-100%
EPS Next Y-103.45%
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.08%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%-21.24%
Revenue Next Year-17.19%
Revenue Next 2Y-6.46%
Revenue Next 3Y-3.79%
Revenue Next 5Y0.49%
EBIT growth 1Y-87.72%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year-25%
EBIT Next 3Y6.69%
EBIT Next 5YN/A
FCF growth 1Y-95.22%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-79.63%
OCF growth 3Y51.49%
OCF growth 5Y5.6%

CONTEXTVISION AB / CONTX.OL FAQ

What is the ChartMill fundamental rating of CONTEXTVISION AB (CONTX.OL) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CONTX.OL.


What is the valuation status for CONTX stock?

ChartMill assigns a valuation rating of 2 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Overvalued.


What is the profitability of CONTX stock?

CONTEXTVISION AB (CONTX.OL) has a profitability rating of 7 / 10.


What is the financial health of CONTEXTVISION AB (CONTX.OL) stock?

The financial health rating of CONTEXTVISION AB (CONTX.OL) is 6 / 10.


What is the expected EPS growth for CONTEXTVISION AB (CONTX.OL) stock?

The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to decline by -103.45% in the next year.